|
ZNF667 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.835600E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.839500E-03 |
| Normal-vs-Stage2 |
6.335800E-01 |
| Normal-vs-Stage3 |
3.296200E-02 |
| Normal-vs-Stage4 |
2.676000E-01 |
| Stage1-vs-Stage2 |
7.061200E-01 |
| Stage1-vs-Stage3 |
7.549000E-01 |
| Stage1-vs-Stage4 |
9.507400E-01 |
| Stage2-vs-Stage3 |
6.149800E-01 |
| Stage2-vs-Stage4 |
7.702800E-01 |
| Stage3-vs-Stage4 |
8.947400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.100220E-03 |
| Normal-vs-AfricanAmerican |
4.707400E-01 |
| Normal-vs-Asian |
6.107400E-01 |
| Caucasian-vs-AfricanAmerican |
2.300200E-01 |
| Caucasian-vs-Asian |
7.407800E-01 |
| AfricanAmerican-vs-Asian |
8.768400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.3438999999943E-05 |
| Normal-vs-Female |
9.282000E-01 |
| Male-vs-Female |
2.848200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.355800E-01 |
| Normal-vs-Extreme_Weight |
5.013300E-04 |
| Normal-vs-Obese |
5.318600E-01 |
| Normal-vs-Extreme_Obese |
1.005840E-02 |
| Normal_Weight-vs-Extreme_Weight |
1.254630E-01 |
| Normal_Weight-vs-Obese |
9.101800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.475400E-01 |
| Extreme_Weight-vs-Obese |
9.640200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.830200E-01 |
| Obese-vs-Extreme_Obese |
1.826810E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.365800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.739930E-02 |
| Normal-vs-Age(61-80Yrs) |
7.219500E-03 |
| Normal-vs-Age(81-100Yrs) |
2.044200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.463850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.229180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.206000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.153000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.888500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.268200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.180000E-02 |
| Normal-VS-Type2 PRCC |
5.28720001113925E-09 |
| Normal-VS-KIRP CIMP |
3.904100E-03 |
| Normal-VS-Unclassified PRCC |
2.388200E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.15649999999657E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.04430000000566E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.000300E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.154200E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.393800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.88680000407149E-08 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.49249999995094E-06 |
| Normal-vs-N1 |
4.148200E-01 |
| Normal-vs-N2 |
8.119600E-01 |
| N0-vs-N1 |
1.497000E-01 |
| N0-vs-N2 |
2.115200E-01 |
| N1-vs-N2 |
9.196400E-01 |
|
|
